Additionally, the systemic infusion of IL-6 NAb attenuates the increase in BBB permeability caused by ischemia [56], while high levels of IL-6 promote BBB disruption and decrease Pgp in Alzheimer’s disease [57]. The gene discussed is PGP; the disease is ischemia.